南京医药 (600713)

Nanjing Pharmaceutical Company Limited

ASH

Tags

SSE 580 IndexSpecial Purpose LoansLow Price-to-Earnings RatioCold Chain LogisticsPharmaceuticals and HealthcarePharmaceutical CommerceInvestments in Financial InstitutionsContains Convertible BondsWholesaleSmart HealthcareBelow Net Asset ValueHigh Accounts Receivable

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 130892.93
  • Circulating A-Shares(W): 128690.45
  • Earnings Per Share(RMB): 0.3100
  • Net Assets Per Share(RMB): 5.3230
  • Operating Revenue(W RMB): 4113514.19
  • Total Profit(W RMB): 70854.57
  • **Net Profit Attributable to Parent(W RMB) **: 40197.12
  • Net Profit Growth Rate(%): -9.03
  • Weighted Return on Equity(%): 5.7900
  • Operating Cash Flow Per Share(RMB): -3.8020
  • Undistributed Profit Per Share(RMB): 2.1619
  • Capital Reserve Per Share(RMB): 1.8752

2. Main Business

The main business covers:

  • Investment and operation of new industrialization projects
  • Venture capital
  • Industrial investment
  • Asset operation, capital operation, non-performing asset disposal
  • Asset entrusted operation
  • Enterprise consulting
  • Project development
  • Property management
  • Financial advisory

3. Company Basic Information

  • Company Name: Nanjing Pharmaceutical Co., Ltd.
  • Listing Date: 1996-07-01
  • Industry: Pharmaceutical Commerce
  • Address: Building 2, No. 55 Andemen Street, Yuhuatai District, Nanjing City, Jiangsu Province
  • Website: https://www.njyy.com
  • Company Profile: The company was jointly established by Nanjing Pharmaceutical Company and three other entities in 1993. Initially, it converted the sponsors' net assets and cash investments into 28.2574 million state shares and 2.5 million legal person shares. It also privately placed 30 million legal person shares and 1.5 million employee shares. After the initial public offering on June 7, 1996, the total shares at listing were 83.0174 million. The 1.5 million internal employee shares were scheduled to become tradable three years after the public shares were listed.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Nanjing Xin Gong Investment Group Co., Ltd. General Legal Person 57820.73 44.93
2 Alliance Healthcare Asia Pacific Limited General Legal Person 14455.74 11.23
3 Jilin Aodong Pharmaceutical Group Co., Ltd. General Legal Person 3015.97 2.34
4 Orient Hongzhong CSI Orient Hongzhong Dividend Low Volatility Index Securities Investment Fund Class A Fund 811.53 0.63
5 Hong Kong Securities Clearing Company Ltd. Northbound Capital 775.91 0.60
6 Invesco Great Wall CSI Shanghai-Hong Kong-Shenzhen Dividend Growth Low Volatility Index Securities Investment Fund 317.23 0.25

5. Concept Sectors

  • Convertible Bonds
  • Smart Healthcare
  • Cold Chain Logistics
  • Financial Holdings
  • Low P/E Ratio
  • Below Net Asset Value
  • High Accounts Receivable
  • Special Loans
  • SSE 580

Remarks

  • Data update date: 2025-09-30
  • Data source: Public market information